Cell Therapy World Asia 2019
Globally, the stem cell therapy market is expected to be worth $40 billion by 2020 and $180 billion by 2030. The largest number of marketed cell therapy products is used for the treatment of notably non-healing wounds/skin (46%) and muscular-skeletal injuries (35%). This trend will change as more and stem cell therapy products for cancer and heart disease complete their clinical trials and are approved for market release.
Adult stem cell leads the market due to low contamination during sub-culture and expansion, relatively low labour production and compatibility with the human body.Just the Induced pluripotent stem cells (IPSc’s) are expected to report revenue of over USD 4.5 billion by 2020, on account of the analogous nature of its origin.With the continued growth of medical tourism hubs like India, Singapore, and Thailand, Asia is expected to maintain its place as the epicentre of stem cell research and therapy. These opportunities include contract research outsourcing and rising patient population with neurological and other chronic conditions in the region. Japan, Singapore and South Korea are the frontrunners and are set to dominate the APAC stem cell market in the coming years.
Cell Therapy World Asia 2019 is bringing together Asia’s best of best in cell therapy development and manufacturing. This will be the most targeted and the only regional conference that will attract cell therapy companies in South Korea, Japan, China, India, Singapore, Taiwan and the rest of Asia to discuss and debate on best practices and innovations in this space.
To become a speaker yourself, contact: Aarthi Asokan, Conference Producer, T: +65 3109 0159, E: firstname.lastname@example.org
Antonio Lee Medipost America Inc
Li Lie Tao Lion TCR
Demao Yang Guangzhou Kang-Hong Therapeutics
Duck Joo Lee Green Cross Cell
Sae Won Kim SL Bigen
JeongHoon Han Eutilex
Hsiu Ling Hsiao Ever Supreme Technology
Yuyus Kusnadi PT Pharmametric Labs
Masayo Takahashi RIKEN Center for Biosystems Dynamics Research
Masayuki Kuroda Chiba University Hospital Center for Advanced Medicine, Medical Department of Chiba University
Alan Trouson Hudson Research Institute
Asuka Morizane Center for iPS Cell Research and Application (CiRA), Kyoto University
Cell Therapy World Asia will provide commercial organizations with the opportunity to:
- Educate the market about what you offer
- Position yourselves as leaders in your field alongside key industry figures.
- Host innovative round – table sessions of up to 20 industry professionals around key topics.
- Host exclusive workshops/master-class of up to 50 end- users
- Raise brand awareness
- Enjoy the option of privately arranged meetings and consultations with selected potential clients.
- Hold face to face meetings with your target profile